Literature DB >> 2378351

Effective testing of gene-disease associations.

M Swift1, L L Kupper, C L Chase.   

Abstract

We propose a method for testing any hypothesized association between a candidate allele, for which there is a specific laboratory test, and a common chronic disease. Families in which this allele is segregating are identified through index individuals who are homozygous or heterozygous for the allele. The sample consists of the subset of identified families who also have at least one member with the common disease of interest. For each independent family in this subset, select one person with the disease and determine if he or she is heterozygous for the allele. The observed proportion of heterozygotes in this sample is compared to the proportion expected on the basis of each diseased relative's null probability of being heterozygous for the allele; this null probability depends only on the relative's relationship to the index individual and the population allele frequency. We provide these null probabilities, develop appropriate inference procedures, discuss sample size requirements, and compare this method to a standard case-control design. Results using this method are unlikely to be influenced by confounders, systematic bias, or genetic heterogeneity.

Entities:  

Mesh:

Year:  1990        PMID: 2378351      PMCID: PMC1683710     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  17 in total

1.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

2.  Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients.

Authors:  T G Krontiris; N A DiMartino; M Colb; D R Parkinson
Journal:  Nature       Date:  1985 Jan 31-Feb 6       Impact factor: 49.962

3.  Increase with age in the prevalence of beta-thalassemia trait among Sicilians.

Authors:  G Schiliro; S Li Volti; S Marino; S P Dibenedetto; P Samperi; R Testa; F Mollica
Journal:  N Engl J Med       Date:  1989-09-14       Impact factor: 91.245

4.  Rare HRAS alleles and susceptibility to human breast cancer.

Authors:  J M Hall; B Huey; J Morrow; B Newman; M Lee; E Jones; C Carter; G C Buehring; M C King
Journal:  Genomics       Date:  1990-01       Impact factor: 5.736

Review 5.  HLA-B27 and the link with rheumatic diseases: recent developments.

Authors:  R W Ebringer
Journal:  Clin Sci (Lond)       Date:  1980-12       Impact factor: 6.124

Review 6.  Cancer predisposition of ataxia-telangiectasia heterozygotes.

Authors:  M Swift; C L Chase; D Morrell
Journal:  Cancer Genet Cytogenet       Date:  1990-05

7.  Cancer mortality in relatives of retinoblastoma patients.

Authors:  L C Strong; J Herson; C Haas; K Elder; R Chakraborty; K M Weiss; P Majumder
Journal:  J Natl Cancer Inst       Date:  1984-08       Impact factor: 13.506

Review 8.  Natural history of alpha-1-protease inhibitor deficiency.

Authors:  D C Hutchison
Journal:  Am J Med       Date:  1988-06-24       Impact factor: 4.965

9.  Strategies for studying heterogeneous genetic traits in humans by using a linkage map of restriction fragment length polymorphisms.

Authors:  E S Lander; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

10.  Breast and other cancers in families with ataxia-telangiectasia.

Authors:  M Swift; P J Reitnauer; D Morrell; C L Chase
Journal:  N Engl J Med       Date:  1987-05-21       Impact factor: 91.245

View more
  2 in total

1.  Missense mutations in disease genes: a Bayesian approach to evaluate causality.

Authors:  G M Petersen; G Parmigiani; D Thomas
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

2.  Transmission-disequilibrium tests for quantitative traits.

Authors:  D B Allison
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.